Malintad, Baby Girl 2 .

HRN: 25-13-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2024
AMPICILLIN 500MG (VIAL)
05/22/2024
05/28/2024
IVT
150mg
Q12
Prophylaxis
Waiting Final Action 
05/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/22/2024
05/28/2024
5
30mg
Q24
Prophylaxis
Waiting Final Action 
05/26/2024
CEFTAZIDIME 1GM (VIAL)
05/26/2024
06/01/2024
IV
117mg
Q12
PSNB
Waiting Final Action 
05/30/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/30/2024
06/05/2024
IV
28mg
OD
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: